Bank Julius Baer & Co. Ltd, Zurich Fulcrum Therapeutics, Inc. Transaction History

Bank Julius Baer & Co. Ltd, Zurich

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Jan 24, 2023	BUY	$5.01 - $8.35 $671 - $1,118	134 Added 1.6%	8,500 $62,000
Q3 2022 Nov 04, 2022	SELL	$4.92 - $9.1 $659 - $1,219	-134 Reduced 1.58%	8,366 $68,000
Q3 2021 Nov 12, 2021	BUY	$7.28 - $30.97 $58 - $247	8 Added 0.09%	8,500 $240,000
Q2 2021 Jul 23, 2021	BUY	$8.09 - $12.0 $68,700 - $101,904	8,492 New	8,492 $89,000

148

51.9M

6.91M

1.9M

Ticker FULC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 52,038,900
Market Cap $220M
Description
Fulcrum Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing products for improving the lives of patients with genetically defined diseases in the areas of high unmet medical need in the United States. Its product candidates are losmapimod, a small molecule for the treatment of facioscapulohumeral muscular dystro...

Get notified when there are updates to the investment portfolio of Bank Julius Baer & Co. Ltd, Zurich, based on Form 13F filings with the SEC.

Stay updated on Bank Julius Baer & Co. Ltd, Zurich with notifications on news.